PKM and hepatocellular carcinoma: These findings suggest that overexpressed and fully activated PKM2 in HCC could accelerate the process of glycolysis to provide hepatoma cells with adequate ATP in an immediate and effective manner, so that some hepatoma cells could escape the apoptosis induced by sorafenib.